Free Stipulation to EXTEND Time - District Court of Delaware - Delaware


File Size: 59.8 kB
Pages: 2
Date: December 31, 1969
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 435 Words, 2,874 Characters
Page Size: 622 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/8652/22.pdf

Download Stipulation to EXTEND Time - District Court of Delaware ( 59.8 kB)


Preview Stipulation to EXTEND Time - District Court of Delaware
Case 1 :04-cv-01300-SLR Document 22 Filed 06/20/2005 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
ETHYPHARM S.A, FRANCE & )
ETHYPHARM S.A. SPAIN, )
)
Plaintiffs ) C.A. No. 04-1300 (SLR)
)
v. )
)
BENTLEY PHARMACEUTICALS, INC. )
)
Defendant. )
)
STIPULATION AND ORDER REGARDING FILING OF SUPPLEMENTAL
MEMORANDUM AND OPPOSITION REGARDING MOTION TO DISMISS
WHEREAS, plaintiffs Ethypharm S.A. France and Ethypharm S.A. Spain
(collectively “Ethypharm”) tiled a complaint against defendant Bentley Pharmaceuticals,
Inc. ("Bentley”) in this Court on September 2004;
WHEREAS, Bentley filed a motion to dismiss the complaint on the basis, among
other things, that Ethyphamfs complaint failed to include a necessary patty, Bentley’s
Spanish subsidiary Laboratories Belmac, S.A. ("Belmac");
WHEREAS, Ethypharm opposed BentIey’s motion to dismiss, and Bentley filed a
reply memorandum in January 2005;
WHEREAS, since the filing of the motion papers, Bentley has learned that
Ethyphann has filed a patent infringement case against Belmac in Spain, which Bentley
believes is relevant to its pending motion to dismiss;
WHEREAS, the parties have agreed to the following schedule for filing a limited
supplemental memorandum and supplemental opposition addressing the impact of these
new facts on the pending motion,

Case 1:04-cv-01300-SLR Document 22 Filed 06/20/2005 Page 2 of 2
The parties agree that:
1. Bentley shall serve and tile a supplemental memorandum of 10 pages or
less limited to the issue of Ethypharrnfs filing ofthe Spanish Patent Action by June 30,
2005.
2. Ethypharm shall serve and file a supplemental opposition of 10 pages or
less responding exclusively to the new issues raised in Bentley’s supplemental
memorandum by July 18, 2005.
3. Bentley shall serve and tile a reply memorandum of 5 pages or less
responding to issues raised in Ethypharnfs supplemental opposition by July 25, 2005.
MURPHY SPADARO & LANDON POTTER ANDERSON & CORROON LLP
By: ls! Francis J. Mumhy By; -»-·< ‘‘‘l=7. i E ‘’“l= ` ``kAl;E;"`“=“‘°‘‘=·»-—l _aH=; N M
Francis J. Murphy (#223) Richard L. Horwitz (#2246)
1011 Centre Road, Suite 210 David E. Moore (#3983)
Wilmington, DE 19805 1313 N. Market Street
(302) 888-6800 P. O. Box 951
Wilmington, DE 19899
Of Counsel (302) 984-6000
Dwight P. Bostwlclc
Bruce R. Grace Of Counsel
Beach Robinson & Lewis PLLC Craig E. Stewart
1201 F Street, NW Suite 500 Marc J. Goldstein
Washington, D.C. 20004 Palmer & Dodge LLP
(202) 833-8900 111 Huntington Avenue
Boston, MA 02199
(617) 239-·0l00
Attarneysyfar Plaimyjfr
Erhypharm S.A. France and Atrarneysfor Defendant
Ethypharm SA. Spain Bentley Pharmaceuticals, Inc
SO ORDERED this day of , 2005.
United States District Judge
687295 2